Αρχική World News Adding Blinatumomab to Chemotherapy Improves DFS in Patients with Newly Diagnosed Childhood... World News Adding Blinatumomab to Chemotherapy Improves DFS in Patients with Newly Diagnosed Childhood Standard-Risk B-Cell ALL of Average or High Risk of Relapse Από Ogkologos - 13 Ιανουαρίου, 2025 1036 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the COG AALL1731 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ AI for early cancer detection: where are we now? Could virtual reality become a reality in cancer supportive care? EMA recommends granting a marketing authorisation for daraxonrasib MOST POPULAR Worse Survival Observed Among Patients Diagnosed with Cancer During the First... 16 Φεβρουαρίου, 2026 Foodie Friday: What to do with all these zucchini? 9 Ιουλίου, 2021 Individualised Nutritional Support Reduce the Risk of Mortality in Cancer Patients... 30 Ιουνίου, 2021 ETV6 Protein Could Be an Important Target for Ewing Sarcoma Treatment 7 Μαρτίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Young District Attorney Diagnosed with Breast Cancer Encourages Others to Get... No OS Benefit for Active Maintenance Treatment with Olaparib Relative to... Approval of Elahere Expands Treatment Options for Some Advanced Ovarian Cancers ASCO Annual Meeting 2023: Improving Outcomes in Glioma, Hodgkin Lymphoma, Lung...